Kobo Biotech Ltd vs Trident Lifeline Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Kobo Biotech Ltd is ₹ 2.85 as of 27 Apr 15:30 . The P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 25.1 on March 2025 . This represents a CAGR of -6.19% over 3 years The Market Cap of Kobo Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 295.53 crore on March 2025 . This represents a CAGR of 17.33% over 3 years The revenue of Kobo Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Trident Lifeline Ltd for the Dec '25 is ₹ 30.34 crore as compare to the Sep '25 revenue of ₹ 33.01 crore. This represent the decline of -8.09% The ebitda of Kobo Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Trident Lifeline Ltd for the Dec '25 is ₹ 9.72 crore as compare to the Sep '25 ebitda of ₹ 8.53 crore. This represent the growth of 13.95% The net profit of Kobo Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Trident Lifeline Ltd changed from ₹ 1.6 crore to ₹ 4.65 crore over 7 quarters. This represents a CAGR of 83.98% The Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kobo Biotech Ltd

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

About Trident Lifeline Ltd

Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014.
Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
It operate in India as well as African, Latin American and East Indian Countries.

FAQs for the comparison of Kobo Biotech Ltd and Trident Lifeline Ltd

Which company has a larger market capitalization, Kobo Biotech Ltd or Trident Lifeline Ltd?

Market cap of Kobo Biotech Ltd is 6 Cr while Market cap of Trident Lifeline Ltd is 298 Cr

What are the key factors driving the stock performance of Kobo Biotech Ltd and Trident Lifeline Ltd?

The stock performance of Kobo Biotech Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kobo Biotech Ltd and Trident Lifeline Ltd?

As of May 4, 2026, the Kobo Biotech Ltd stock price is INR ₹2.85. On the other hand, Trident Lifeline Ltd stock price is INR ₹250.05.

How do dividend payouts of Kobo Biotech Ltd and Trident Lifeline Ltd compare?

To compare the dividend payouts of Kobo Biotech Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.